Kora Saúde Participações S.A.
KRSA3.SA
B3 S.A.8.87
BRL
-0.02
- -
Kora Saúde Participações S.A.
KRSA3.SA
(B3 S.A.)
Recent
price
8.87
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Kora Saúde Participações S.A. operates as a leading private hospital group in Brazil, specializing in the management and operation of healthcare facilities. The company provides comprehensive healthcare services including hospital care with over 2,000 beds across 17 hospitals located in the states of Espírito Santo, Mato Grosso, Tocantins, Goiás, Ceará, and the Federal District. Kora Saúde offers a broad range of medical services including urgent care, organ transplantation, advanced clinical treatments, and diagnostic and therapeutic support services such as oncology, clinical radiology, and hemodynamics. The company primarily serves private health insurance holders and individual patients, positioning itself as a provider of high-complexity medical procedures and hospital care. Founded in 2001 and headquartered in Cariacica, Espírito Santo, Kora Saúde has expanded its geographic footprint to multiple Brazilian states and satellite cities around the Federal District. Its operations include hospital expansion projects (both brownfield and greenfield), aiming to increase capacity and modernize facilities. The company entered the public market with an IPO in August 2021, backed by the US private equity firm HIG Capital, which has been a significant shareholder since 2018. Recent major developments include the acquisition of a majority stake in Instituto de Neurologia de Goiânia for approximately BRL 140 million, enhancing its neurological care capabilities. Kora Saúde is also engaged in negotiations to restructure parts of its debt and has plans to raise equity to improve its financial position. The company has pursued strategic growth through acquisitions and partnerships while continuing to expand its healthcare services portfolio and geographic reach, focusing on innovation and high-complexity care delivery. Additionally, there have been efforts by its majority shareholder to potentially delist the company from the Brazilian stock exchange to streamline operations. Kora Saúde’s core business encompasses hospital management; diagnostic and therapeutic service provision; specialized treatments including organ transplants; and operating healthcare networks across Brazil’s key states, targeting private sector healthcare demand. Its strategic initiatives over the last two years reflect a focus on scaling operational capacity, improving financial health, and broadening its specialty care offerings in cutting-edge medical fields such as oncology and neurology. This comprehensive healthcare platform makes Kora Saúde one of the prominent players in Brazil’s private hospital industry with a commitment to quality, technological advancement, and expanding access to complex medical services across its regional operations.